Elucidating mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2210711
Recipient
Awarding agency
Obligated
$506,554

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Portland, OR 97239, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by developing innovative medical solutions for Service Members and the battlefield. This particular award supports the program's goals by investigating the underlying causes of swift cancer recurrence to identify potential new treatment approaches for pancreatic cancer.

Quick answers

Who received award W81XWH2210711?

W81XWH2210711 was awarded to Oregon Health & Science University by Medical Command (Department of the Army) on July 15, 2022.

How much is award W81XWH2210711 worth?

$506,554 has been obligated on W81XWH2210711.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login